Thyroid Function Tests Explained: Understanding TSH, Free T4, Free T3 and Thyroid Antibodies

This article provides general health education. It does not diagnose hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis, Graves' disease, pituitary disease or any other thyroid condition, and it does not recommend personalised treatment.

Thyroid blood tests should be interpreted using the reference intervals supplied by the laboratory that performed the test, alongside symptoms, medical history, medications, supplements, pregnancy status, previous thyroid treatment and other relevant investigations.

Urgent medical assessment may be necessary when significant thyroid abnormalities occur alongside serious symptoms such as severe breathlessness, chest pain, marked palpitations, fainting, significant confusion, extreme weakness, very high fever or rapidly deteriorating health.

Thyroid tests appear straightforward.

A report might show:

TSH: 6.8 mIU/L — High

or:

TSH: 0.05 mIU/L — Low

It is tempting to translate these immediately into:

High TSH = underactive thyroid

and:

Low TSH = overactive thyroid.

Those statements are often directionally correct—but they are not enough.

The thyroid operates within a feedback system involving the hypothalamus, pituitary gland and thyroid gland. TSH does not come from the thyroid itself. It comes from the pituitary gland and acts as the signal telling the thyroid how much hormone to produce.

That means an abnormal TSH can arise because the thyroid itself is malfunctioning, because the pituitary or hypothalamus is malfunctioning, because the body is temporarily affected by another illness, because medication has altered hormone production, or because the laboratory measurement itself has been distorted.

This is why clinicians interpret patterns.

A TSH of 8 mIU/L with FT4 below range has a different meaning from a TSH of 8 with FT4 comfortably inside the reference interval.

Likewise, a low TSH with high FT4 has a different interpretation from a low TSH with normal FT4 and FT3.

NICE guidance therefore bases assessment on combinations of TSH, FT4 and—in particular circumstances—FT3 rather than treating them as independent biomarkers.

The thyroid is a butterfly-shaped endocrine gland located at the front of the neck.

Its principal hormones are:

thyroxine (T4) triiodothyronine (T3).

T4 is produced in greater quantities by the thyroid. T3 is biologically more active, and much of the body's T3 is produced outside the thyroid by conversion from T4. The American Thyroid Association notes that T3 testing is generally less useful for diagnosing hypothyroidism because circulating T3 can remain normal even when thyroid function is beginning to decline.

Thyroid hormones influence metabolic activity throughout the body and affect systems including:

cardiovascular function, temperature regulation, gastrointestinal activity, nervous-system function, muscle function, reproductive health, growth and development.

This broad biological reach explains why thyroid symptoms can be diverse and nonspecific.

Understanding thyroid tests becomes much easier once you understand the feedback loop.

Step 1: The hypothalamus

The hypothalamus produces thyrotropin-releasing hormone (TRH).

TRH stimulates the pituitary gland.

Step 2: The pituitary gland

The pituitary releases:

thyroid-stimulating hormone — TSH

TSH travels through the bloodstream and stimulates the thyroid.

Step 3: The thyroid gland

The thyroid produces mainly T4 and a smaller amount of T3.

Step 4: Negative feedback

When circulating thyroid hormone concentrations rise, the brain reduces TSH stimulation.

When thyroid hormone concentrations fall, the pituitary usually increases TSH.

This feedback relationship is highly sensitive.

The American Thyroid Association describes TSH as an "early warning" measure because relatively small changes in circulating thyroid hormone can lead to larger changes in TSH.

A high TSH often means:

"The pituitary is asking the thyroid to work harder."

A low TSH often means:

"The pituitary is reducing stimulation because thyroid hormone activity appears high."

That analogy works well for primary thyroid disease, but becomes less reliable if the pituitary itself is abnormal.

TSH—also called thyrotropin—is produced by the anterior pituitary gland.

For adults without suspected pituitary disease, NICE recommends TSH as the first test when thyroid dysfunction is suspected, with additional hormone measurements guided by the TSH result. NHS laboratories commonly use this "cascade" approach.

A high TSH usually suggests that the thyroid is not producing enough hormone.

A low TSH usually suggests that there is too much thyroid hormone effect.

But "usually" is the important word.

TSH interpretation can change in:

pituitary disease, pregnancy, severe illness, recent treatment for hyperthyroidism, people taking thyroid hormone, people taking amiodarone or lithium, and some laboratory interference states.

T4 circulates in blood largely bound to proteins.

Only a small fraction is unbound or free.

The Free T4 test attempts to measure this unbound fraction.

FT4 is particularly useful when TSH is abnormal because the combination helps distinguish overt thyroid dysfunction from milder biochemical abnormalities.

For example:

High TSH + low FT4

strongly supports primary hypothyroidism.

But:

High TSH + normal FT4

may represent subclinical hypothyroidism.

Likewise:

Low TSH + high FT4

supports overt hyperthyroidism, whereas:

Low TSH + normal FT4

requires FT3 and additional clinical context.

T3 is the more biologically active thyroid hormone.

FT3 testing is especially helpful when hyperthyroidism is suspected.

Some people develop T3-predominant thyrotoxicosis, where FT3 is elevated while FT4 remains within range.

For this reason, NHS laboratory pathways may add FT3 when TSH is suppressed or when the clinical pattern suggests T3 toxicosis.

FT3 is generally much less useful for diagnosing ordinary primary hypothyroidism. The ATA notes that T3 often remains normal until hypothyroidism is relatively advanced.

The following table shows common biochemical patterns.

These are educational patterns rather than diagnoses. Clinical interpretation may differ depending on treatment status, pregnancy, recent illness and medication.

There is no universal TSH reference range.

A current example from Gloucestershire Hospitals NHS Foundation Trust, updated 1 July 2026, reports the following adult ranges:

But another NHS laboratory reports TSH 0.38–5.33 mU/L, FT4 8–18 pmol/L and FT3 3.7–6.6 pmol/L.

That difference is not a mistake.

Laboratories use different assays and establish their own validated reference intervals.

Therefore, avoid entering a thyroid result into an online calculator without checking the reference interval printed beside your own result.

A high TSH means the pituitary is providing stronger-than-usual stimulation to the thyroid.

In the most common pattern of primary hypothyroidism, the thyroid is failing to produce sufficient hormone, so FT4 falls and TSH rises.

NHS guidance confirms that hypothyroidism is assessed with TSH and T4 testing, and NICE describes overt primary hypothyroidism as elevated TSH with FT4 below range.

Possible causes include:

Hashimoto's autoimmune thyroiditis, previous thyroid surgery, radioactive iodine treatment, some medications, iodine-related disorders, thyroid inflammation, congenital or structural thyroid disease.

However, not every mildly high TSH represents permanent thyroid failure.

TSH can fluctuate, and borderline elevations may need confirmation before they are labelled persistent thyroid dysfunction. NICE defines subclinical hypothyroidism using persistently elevated TSH with normal FT4, and management decisions depend partly on the magnitude and persistence of the elevation.

A low or suppressed TSH often indicates excessive thyroid hormone activity.

Common causes include:

Graves' disease, autonomously functioning thyroid nodules, toxic multinodular goitre, thyroiditis, excessive thyroid-hormone replacement, some medication effects.

The NHS describes the typical pattern of hyperthyroidism as low TSH with elevated T3 and/or T4.

But a low TSH by itself is not enough to diagnose hyperthyroidism.

TSH can remain suppressed for a period even after hyperthyroidism treatment has begun, which is why FT4 and FT3 may be more useful during early treatment monitoring. Gloucestershire Hospitals NHS guidance specifically notes that TSH may remain suppressed for months after treatment for thyrotoxicosis begins.

The word subclinical can be misleading.

It does not necessarily mean "no symptoms."

Subclinical hypothyroidism is defined biochemically by:

TSH above the laboratory reference range

with:

FT4 remaining within range.

The degree of TSH elevation matters.

NICE distinguishes persistent TSH concentrations below 10 mIU/L from higher values because the likelihood of progression and potential benefit from treatment differ.

Symptoms alone cannot reliably distinguish subclinical hypothyroidism from other conditions because fatigue, weight change, mood symptoms, dry skin and concentration problems are highly nonspecific.

If FT4 remains normal, the biochemical situation is very different from someone whose TSH is high and FT4 is clearly below range.

Subclinical hyperthyroidism is the reverse pattern:

TSH below the reference range

while:

FT4 and FT3 remain within range.

Potential explanations include early Graves' disease, autonomous thyroid nodules, medication effects and temporary thyroid inflammation.

Its importance varies with how suppressed TSH is, how long the abnormality persists, age, symptoms and cardiovascular or bone-health risk.

A single low TSH should therefore not automatically trigger the conclusion that someone has permanent hyperthyroidism.

Hashimoto's thyroiditis is an autoimmune form of thyroid disease.

The immune system produces antibodies directed against thyroid-related proteins, particularly:

thyroid peroxidase antibodies — TPOAb

and sometimes:

thyroglobulin antibodies — TgAb.

The American Thyroid Association notes that these antibodies can support an autoimmune cause of hypothyroidism.

NICE recommends considering TPO antibody testing in adults with TSH above the reference range, but advises against repeatedly measuring TPO antibodies once they have been identified because repeated antibody titres generally do not guide management.

This leads to an important distinction:

TPO antibodies tell you about autoimmunity.

TSH and FT4 tell you about current thyroid function.

A person can have positive TPO antibodies and normal thyroid hormone tests.

The ATA states that thyroid hormone treatment is generally not required solely because antibodies are positive when TSH and FT4 remain normal.

Graves' disease is an autoimmune disorder in which antibodies stimulate the TSH receptor.

These antibodies may be reported as:

TRAb — TSH receptor antibodies TSI — thyroid-stimulating immunoglobulins.

A positive TRAb or TSI result in the appropriate clinical and biochemical setting strongly supports Graves' disease. The American Thyroid Association states that a positive receptor-antibody test can confirm Graves' disease without additional diagnostic testing in many cases.

The typical blood pattern is:

low/suppressed TSH

with:

high FT4 and/or FT3.

Other findings can include a diffusely enlarged thyroid and, in some people, Graves' eye disease.

This point deserves emphasis.

Someone may have:

positive TPO antibodies

but:

normal TSH and normal FT4.

That means autoimmune thyroid activity is detectable, but current thyroid hormone production may still be adequate.

Likewise, antibody concentrations are not a reliable measure of how "severe" symptoms should be.

The ATA specifically states that following TPO or thyroglobulin antibody levels over time is generally not useful for determining thyroid function; TSH and FT4 are the important functional markers.

Usually, a normal TSH makes primary hypothyroidism less likely.

But there is an important exception:

central hypothyroidism

This occurs when the pituitary or hypothalamus fails to provide appropriate TSH stimulation.

In that situation, FT4 may be low while TSH is low, normal or inappropriately only mildly elevated.

This is why NICE recommends measuring TSH and FT4 together when pituitary disease is suspected rather than relying on TSH alone.

This is one reason laboratory interpretation cannot be completely automated without clinical context.

Hypothyroidism can develop gradually.

NHS-described symptoms include manifestations such as:

fatigue, feeling unusually cold, weight gain, constipation, difficulty concentrating, low mood, dry skin, dry or thinning hair, muscle aches, menstrual changes.

These symptoms are not specific. Many occur in people without thyroid disease. Diagnosis therefore depends on the clinical picture plus biochemical testing rather than symptoms alone.

Severe longstanding hypothyroidism is uncommon in settings with ready access to testing and treatment, but can produce more significant systemic illness.

Hyperthyroidism can produce a different cluster of symptoms, including:

palpitations, rapid heartbeat, tremor, heat intolerance, sweating, anxiety or irritability, unexplained weight loss, increased bowel frequency, muscle weakness, sleep disturbance.

Again, these symptoms have many alternative causes, so blood testing is needed to confirm thyroid dysfunction.

Yes.

Laboratory testing is highly useful but no test is immune to interference.

A surprising result should therefore be considered in context, particularly when it does not match the person's symptoms or previous results.

Important sources of misleading thyroid results include:

biotin, acute illness, pregnancy-related physiological change, certain medications, antibody interference, timing during thyroid treatment, changes in thyroid-binding proteins.

Biotin is vitamin B7.

It is commonly included in supplements marketed for:

hair, skin, nails, beauty, multivitamin support.

Biotin itself does not necessarily make the thyroid overactive.

The problem is laboratory interference.

Certain immunoassays use biotin-related chemistry. High circulating biotin can interfere with those tests and produce results that mimic thyroid disease.

A characteristic misleading pattern can include:

falsely low TSH

and:

falsely high T4 and T3.

This can resemble Graves' hyperthyroidism.

NICE reviewed this issue in its 2023 exceptional surveillance and highlighted the potential for supplementary biotin to cause falsely increased or decreased results.

Advice about how long to stop biotin before testing varies according to dose and laboratory method. ATA educational material has suggested at least 2 days in some circumstances and 3–5 days for high-dose supplementation, while individual laboratories may issue assay-specific instructions.

Follow the instructions from the laboratory or clinician rather than applying a universal online rule.

Significant non-thyroid illness can temporarily alter TSH, FT4 and FT3 without primary thyroid disease.

This phenomenon is sometimes called:

non-thyroidal illness syndrome

or:

euthyroid sick syndrome.

Because interpretation can be difficult, NHS laboratory guidance advises against routine thyroid testing during acute inpatient illness unless there is a strong clinical suspicion of genuine thyroid disease.

This is another reason why a thyroid result obtained during a severe infection, major operation or critical illness may not mean the same thing as the same result obtained when someone is otherwise well.

Several medications can influence thyroid physiology or test interpretation.

Amiodarone

Amiodarone is an anti-arrhythmic drug containing substantial iodine and can produce complex changes in TSH, FT4 and FT3.

It can also cause genuine hypothyroidism or hyperthyroidism.

NHS laboratory guidance recommends thyroid assessment before amiodarone treatment and ongoing monitoring during stable therapy.

Lithium

Lithium can affect thyroid function and increase the risk of hypothyroidism in susceptible individuals.

Thyroid monitoring is therefore part of ongoing lithium safety surveillance.

Thyroid hormone medication

Levothyroxine and liothyronine obviously alter circulating thyroid hormone levels.

When interpreting a test, clinicians need to know:

what medication is being taken, the dose, how consistently it is taken, when the dose was last changed, and sometimes when the tablet was taken relative to the blood sample. Antithyroid medicines

Drugs used to treat hyperthyroidism alter thyroid hormone synthesis.

During early treatment, FT4 and FT3 can be more informative than TSH because TSH may remain suppressed for an extended period.

Thyroid hormone systems respond over time, not instantly.

Repeating blood tests too quickly can therefore produce confusing information.

The Gloucestershire NHS laboratory advises waiting at least 2 months after a thyroid-hormone replacement change before repeat testing in its local pathway.

Specific monitoring intervals depend on:

diagnosis, medication, pregnancy, age, severity, whether treatment has recently changed.

Do not assume that checking TSH every few days provides useful information.

Pregnancy substantially alters thyroid physiology.

Human chorionic gonadotropin (hCG) can stimulate the TSH receptor, particularly during early pregnancy, which can lower maternal TSH. Thyroid-binding proteins also change, and FT4 interpretation becomes assay and trimester dependent.

For this reason, pregnancy-specific reference intervals should be used where available.

For example, the Gloucestershire NHS laboratory currently publishes trimester-specific ranges that differ from its non-pregnant adult ranges.

This is another strong argument against interpreting pregnancy thyroid results using generic internet ranges.

Yes.

TSH distribution can shift with age, and age-specific interpretation may be relevant, particularly in older people.

The American Thyroid Association has highlighted evidence showing that thyroid hormone distributions vary across age groups and that applying one rigid adult range to every older adult can risk over-classification of mild abnormalities.

Clinical interpretation therefore becomes increasingly important when the abnormality is mild.

Reverse T3—or rT3—is an inactive metabolite of T4.

It is frequently promoted in some commercial thyroid-testing packages.

However, routine reverse T3 testing is generally not useful for diagnosing hypothyroidism in otherwise stable people.

The American Thyroid Association states that reverse T3 measurement does not help determine whether hypothyroidism exists in healthy, non-hospitalised people and is not clinically useful for that purpose.

A premium health panel containing ten thyroid markers is not necessarily more clinically useful than a properly interpreted TSH and FT4.

No.

Thyroglobulin (Tg) is a protein produced by thyroid cells.

It is primarily used as a tumour marker in certain people who have been treated for differentiated thyroid cancer.

It is not a routine test for deciding whether the thyroid is underactive or overactive.

This distinction matters because commercial blood-test panels sometimes include thyroglobulin alongside TSH and thyroid antibodies, which can make it appear as though all of these markers assess the same thing.

They do not.

Blood tests tell you primarily about function.

An ultrasound tells you primarily about structure.

Someone can have:

completely normal TSH and FT4, but still have a thyroid nodule.

Conversely, someone can have significant hypothyroidism without a major structural abnormality visible on ultrasound.

The two assessments answer different questions.

Thyroid ultrasound is useful for evaluating nodules, gland morphology and certain structural abnormalities but is not a substitute for biochemical thyroid function testing.

Most mild thyroid abnormalities are assessed in routine clinical care.

However, faster evaluation may be appropriate when markedly abnormal thyroid tests occur alongside:

persistent rapid heartbeat, severe palpitations, chest pain, breathlessness, fainting, significant agitation or confusion, very high fever, severe weakness, marked deterioration in general health, pregnancy with significant thyroid dysfunction.

Severe untreated hyperthyroidism can rarely progress to thyroid storm, while profound hypothyroidism can rarely cause severe systemic decompensation. These are uncommon but serious conditions requiring urgent medical care.

The presence of symptoms matters more than simply crossing an arbitrary laboratory threshold.

Blood Tests & Biomarkers HbA1c Explained: Understanding Your Blood Sugar Over Time Ferritin Explained: Understanding Your Iron Stores Vitamin B12 Explained Vitamin D Explained High Creatinine: What an Elevated Creatinine Blood Test Means Liver Enzymes Explained Complete Blood Count Explained MCV Explained: High and Low MCV Calcium Blood Test Explained Thyroid Antibodies Explained CRP Explained: Understanding Inflammation Iron, Ferritin, Transferrin and TIBC Explained Understanding Medical Reports What Does "Unremarkable" Mean on a Scan? What Does "Mild Degenerative Changes" Mean? What Does "Clinical Correlation Recommended" Mean?

Your TSH result is a snapshot. Your thyroid health is a timeline.

Thyroid blood tests become much more meaningful when you can see how they change over time.

A single result may show:

TSH 4.9 mIU/L

But a longitudinal view might show:

TSH 2.1 → 2.8 → 4.2 → 4.9

FT4 17 → 16 → 14 → 12

TPO antibodies Positive

That pattern provides far more context than a single red flag beside "TSH."

Healio360 helps connect those pieces.

Bring blood tests, imaging reports, medications, symptoms and health information together to build a longitudinal view of your medical history.

Instead of asking only:

"Is my TSH normal?"

you can begin asking:

"How has it changed?"

"What happened to FT4 at the same time?"

"Were thyroid antibodies tested?"

"Did the result change after medication?"

"Was the test taken during illness or pregnancy?"

"Is this a persistent pattern or a one-off abnormality?"

Turn fragmented medical data into a clearer health story.

Healio360 provides educational health information and tools to help organise and understand health records. It does not diagnose disease, replace healthcare professionals or provide personalised treatment recommendations.